LD-2 disclosure · 4th Quarter - Report
VYRIPHARM ENTERPRISES, INC.
via CORNERSTONE GOVERNMENT AFFAIRS, INC.
Client
- Name
- VYRIPHARM ENTERPRISES, INC.
- Description
- Scientific research and development
- Location
- Texas · United States of America
Registrant
- Firm
- CORNERSTONE GOVERNMENT AFFAIRS, INC.
- Description
- Government relations and consulting.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesFood Industry (safety, labeling, etc.)
Policies and regulations associated with testing, tracing and tracking of cannabinoids.
LobbyistsTONY ESSALIH · JOSEPH BISCHOFF · ELLIOTT FLAGGS
Covered position (TONY ESSALIH): COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Natl Drug Control Policy (NDCP)
Health Issues
Policies and regulations associated with testing, tracing and tracking of cannabinoids.
LobbyistsTONY ESSALIH · JOSEPH BISCHOFF · ELLIOTT FLAGGS
Covered position (TONY ESSALIH): COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Natl Drug Control Policy (NDCP)
Pharmacy
Policies and regulations associated with testing, tracing and tracking of cannabinoids.